
biote Corp.
BTMDNASDAQHealthcare● Active
$2.35
+$0.01(+0.21%)
Market Cap$103432174
P/E Ratio—
52W High$4.75
52W Low$1.27
biote Corp.(BTMD)· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · BTMD · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.19B | $0.20B | $0.19B | $0.16B | $0.14B |
| Cost of Revenue | $0.06B | $0.06B | $0.06B | $0.05B | $0.05B |
| Gross Profit | $0.13B | $0.14B | $0.13B | $0.11B | $0.09B |
| Gross Margin %(computed) | 69.76% | 70.52% | 68.78% | 66.92% | 64.98% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.17B | $0.05B |
| Total Operating Expenses | $0.09B | $0.11B | $0.10B | $0.17B | $0.06B |
| Operating Income | $0.04B | $0.03B | $0.03B | ($0.06B) | $0.03B |
| Operating Margin %(computed) | 20.35% | 16.03% | 15.46% | -36.81% | 24.79% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.01B | $0.01B | $0.00B | $0.00B |
| Income Before Tax | $0.04B | $0.00B | ($0.00B) | $0.00B | $0.03B |
| Income Tax Expense | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | $0.03B | $0.00B | $0.00B | ($0.00B) | $0.03B |
| Net Margin %(computed) | 14.07% | 1.60% | 1.79% | -0.59% | 23.40% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.86 | $0.09 | $0.13 | $0.16 | $-0.87 |
| Wtd Avg Shares | 0.03B | 0.03B | 0.03B | 0.01B | 0.01B |
| EBITDA | $0.04B | $0.02B | $0.04B | $0.01B | $0.04B |
| EBITDA Margin %(computed) | 22.26% | 7.91% | 21.33% | 4.82% | 25.81% |
数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · B
深入了解biote Corp.
关于biote Corp.(BTMD)损益表
biote Corp.(BTMD)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,BTMD实现营收$0.19B,毛利润$0.13B(毛利率69.76%),净利润$0.03B(净利率14.07%)。
常见问题
BTMD · 4 问biote Corp.(BTMD)2025财年营收为$0.19B,同比down2.5%。
BTMD revenueBTMD salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09